Translation for the Pharmaceutical Industry: What We Handle
Pharmaceutical companies need translation at almost every stage of a drug's life: clinical trial protocols and informed consent forms during research, regulatory submission documents (like Summary of Product Characteristics and Patient Information Leaflets) for market authorization, GMP and quality documentation for manufacturing, and pharmacovigilance reports once a drug is on the market.
Each of these document types has its own expected structure and terminology conventions that regulatory authorities (like Egypt's EDA or the UAE's MOHAP) look for — a translation that reads well but does not follow the expected format can slow down a submission even if every sentence is accurate.
We work with pharmaceutical and medical device clients on exactly this kind of documentation, with translators who have a life-sciences background and are familiar with the regulatory format these authorities expect.